Precision Neuroscience develops brain-computer interface technology aimed at enabling people to operate digital devices through thought. The company offers the Layer 7 Cortical Interface, which is a minimally invasive implant designed to interface with the brain.

Precision Neuroscience

Manufacturing

Precision BioMEMS

Precision Neuroscience | 18,676 followers on LinkedIn. Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from neurological illnesses. We are building the only brain–computer interface that is designed to be minimally invasive, safely removable, and capable of processing large amounts of data. To learn more about how Precision is connecting human intelligence and artificial intelligence, visit www.precisionneuro.io.

Managing Partner @ Alumni Ventures

Ludwig Pierre Schulze

General Partner @ B Capital Group | MBA- Kellogg School of Management | Early and Growth Stage Venture Capital

Gabe Greenbaum

BCI Evangelist @Precision | -Ex Neuralink | -Ex HubSpot

Joe Sharron

President and Chief Product Officer @ Precision Neuroscience

Craig Mermel

Terrific recap by Naveen Rao of the New York BCI Symposium #NYBCI24 , hosted by Mount Sinai Health System As Naveen notes, Mount Sinai has helped to make New York City into a hub of neurotech innovation. For two days, a who’s who of researchers, neurosurgeons, founders, advocates, and federal leaders got together to discuss the present and future of this fast-moving field. 🧠 ⚡ Read the story below. The photo is from the BCI Startup Spotlight panel, moderated by Bloomberg’s Sarah McBride and featuring Precision's Benjamin Rapoport alongside leaders from Synchron , Paradromics Inc. , Blackrock Neurotech , Science , and Meta https://lnkd.in/dPvPQTFU #neuralEngineering #Neurosurgery #neurotech #medtech #biomed #neuroscience #BCI #Innovation #Neuroscience #Healthcare #FutureOfMedicine #Neurotech #Neurosurgery

“When we are successful in deploying these types of technologies, what it will demonstrate is that we understand the brain and its inner workings. And that’s going to have a foundational impact on who we think we are, and how we explain our behavior.” - Dr. Bijan Pesaran , Robert A Groff Professor of Neurosurgery II, Neuroscience and Bioengineering. Don’t miss this incredible video by Penn Medicine, University of Pennsylvania Health System documenting some of the groundbreaking research being done with Precision Neuroscience 's Layer 7 Cortical Interface. Dr. Pesaran and Dr. Iahn Cajigas , reveal how advanced neurosurgical techniques and high-resolution brain mapping could soon enable thought-based control of prosthetic limbs—offering hope for patients with paralysis and revolutionizing our understanding of the human brain. University of Pennsylvania Perelman School of Medicine #PennMedicine

Precision Neuroscience CEO and Co-Founder Michael Mager recently spoke at The Information ’s AI Summit in San Francisco. Read the recap below for highlights from his discussion with other health tech leaders about applications of AI in healthcare, its potential economic value, and how, in many ways, the future of AI-assisted healthcare is already here. Ayman AlAbdallah Mubadala Capital Michael Ng Ambience Healthcare #BrainComputerInterface #AIinHealthcare

Explore the future of brain-computer interfaces at the New York BCI Symposium this weekend, November 1-2, 2024, in New York City! Precision Neuroscience ’s Co-founder and Chief Science officer, Dr. Benjamin Rapoport , will be sharing some of Precision’s early clinical experiences in his keynote speech, highlighting surgical techniques for implantable BCIs. He will be joined by speakers from other groundbreaking neurotech companies, including Synchron , Blackrock Neurotech , and Paradromics Inc. . Topics of discussion will include BCI translation, implementation, and commercialization—as well as the latest advancements in a technology that stands to enhance quality of life for millions of people with neurological conditions. There’s still time to register: https://www.nybci.com #NYBCI24 Mount Sinai Neurosurgery #BrianComputerInterface

October 29th is World Stroke Day. Commit to learning and sharing the B.E.F.A.S.T. warning signs. You just might save a life from stroke. Strokes can happen to anyone, at any age. On average, 1.9 million brain cells die every minute that a stroke goes untreated. Globally, about one in four adults over the age of 25 will have a stroke in their lifetime. Yet most adults don’t know the B.E.F.A.S.T. warning signs of a stroke, or that stroke is largely treatable if you call emergency services as soon as you recognize the symptoms. Help reduce your and your loved ones’ stroke risk today. Learn more about stroke, and stroke prevention from the American Heart Association here: https://lnkd.in/eajh5Kz #WorldStrokeDay #StrokeAwareness #StrokeSurvivor #StrokePrevention

Precision Neuroscience 's Michael Mager and Dr. Benjamin Rapoport joined some of tech’s biggest newsmakers at The Wall Street Journal Tech Live this week, where they spoke to Rolfe Winkler in a session titled, “Exponential Impact: AI and Brain-Computer Interfaces.” They broke down how Precision’s approach to BCIs differs from that of competitors like Neuralink , and they delved into the real-world impact of a technology that can sometimes seem like science fiction. “Over the next couple of years, you’re going to be seeing people doing amazing things that we never could have possibly imagined with brain-controlled computers,” Dr. Rapoport said. When it comes to treating neurological disorders–a category that includes everything from Autism to depression to stroke recovery to Alzheimer’s–he emphasized that the field is just getting started. Mager added, “We see this as the beginning.” Watch the interview from The Wall Street Journal’s Tech Live 2024 here: https://lnkd.in/eQUvi8Mw

What do the Mars Rover, Harvard Medical School , and cardiovascular fitness trackers have to do with the origins of one of the world's leading brain-computer interface (BCI) companies? Read the article below from Harvard Medicine to find out. The story covers Precision Neuroscience 's clinical research with Penn Medicine, University of Pennsylvania Health System and even weaves in a brief but fascinating history of brain-computer interfaces, beginning with computer science professor Jacques Vidal’s coinage of the term in 1973. Read more in the article below.

Morgan Stanley has released a report describing brain-computer interfaces (BCI) as the next big MedTech opportunity. They foresee the commercialization of BCIs for medical purposes within the next five years and project a $400B market opportunity in the U.S. alone, $1.5 billion in revenue generated by 2035, and a $1B annual run rate by 2041. According to the report, initial indications will focus on disease states such as ALS, spinal cord injury, and stroke—all of which Precision Neuroscience has been diligently working on. We’re honored to be working alongside companies like Neuralink , Paradromics Inc. , Blackrock Neurotech and Synchron to push this industry forward. It will be significant, and, most importantly, it will have a transformational impact on the lives of millions of people affected by neurological conditions.

Precision Neuroscience ’s Co-founder and CEO, Michael Mager , and Co-founder and Chief Science Officer, Dr. Benjamin Rapoport , will be featured speakers this coming week at WSJ Tech Live, The The Wall Street Journal 's flagship technology conference, in a session titled, “Exponential Impact: AI and Brain–computer interfaces.” They’ll be joining some of the biggest newsmakers in tech, including Netflix ’s Ted Sarandos , Reddit, Inc. ’s Steve Huffman , Amazon Web Services (AWS) ’s Matt Garman , and LinkedIn ’s Reid Hoffman , for what promises to be a lively series of discussions. #WSJTechLive will take place in Laguna Beach, California, from October 21-23. Learn more, and register here: https://lnkd.in/eyiWR-qF

Metric
Company Name	Precision Neuroscience
Symbol
MSH ID	IO:PRECISIONNEURO
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Medical Devices
Country	US
Stage
Employee Count
Website	precisionneuro.io
LinkedIn	precision-neuroscience-corporation
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	2.81K
Web Traffic Growth	-0.73
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

PREC

IO:PRECISIONNEURO

Precision Neuroscience

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue